Phase II study of NGR-hTNF, a vascular targeting agent, in combination with doxorubicin in patients with relapsed small cell lung cancer (SCLC)

被引：0
|
作者：
Gregorc, V.
Novello, S.
Santoro, A.
Grossi, F.
Levra, M. Giaj
Cavina, R.
Vigano, M.
Caligaris-Cappio, F.
Lambiase, A.
Bordignon, C.
机构：
[1] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[2] Univ Turin, Orbassano, Italy
[3] Ist Clin Humanitas, Rozzano, Italy
[4] Natl Inst Canc Res, Genoa, Italy
[5] Univ Turin, AUO San Luigi, Thorac Oncol Unit, Orbassano, Italy
[6] Ist Clin Humanitas, Dept Oncol, Rozzano, Italy
[7] MolMed SpA, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e18043
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18043
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC)
    Vigano, M. G.
    Cavina, R.
    Novello, S.
    Grossi, F.
    Santoro, A.
    Gregorc, V.
    Scagliotti, G.
    Garassino, I. M.
    Rossoni, G.
    Levra, M. G.
    Genova, C.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Phase II Trial of NGR-hTNF and Doxorubicin in Relapsed Small Cell Lung Cancer (SCLC)
    Vigano, M.
    Cavina, R.
    Novello, S.
    Grassi, F.
    Santoro, A.
    Gregorc, V.
    Rossoni, G.
    Levra, M. G.
    Lambiases, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S623 - S623
  • [3] NGR-HTNF IN COMBINATION WITH DOXORUBICIN IN RELAPSED SMALL-CELL LUNG CANCER (SCLC)
    Gregorc, V.
    Santoro, A.
    Novello, S.
    Grossi, F.
    Levra, M. Giaj
    Cavina, R.
    Vigano, M. G.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 149 - 150
  • [4] NGR-HTNF PLUS DOXORUBICIN IN RELAPSED SMALL CELL LUNG CANCER (SCLC)
    Novello, Silvia
    Cavina, Raffaele
    Vigano, Maria G.
    Grossi, Francesco
    Santoro, Armando
    Gregorc, Vanesa
    Scagliotti, Giorgio
    Garassino, Isabella
    Rossoni, Gilda
    Levra, Matteo G.
    Genova, Carlo
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1348 - S1349
  • [5] NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC)
    Cavina, Raffaele
    Gregorc, Vanesa
    Novello, Silvia
    Grossi, Francesco
    Santoro, Armando
    Vigano, Maria Grazia
    Levra, Matteo G.
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
    Lorusso, D.
    Scambia, G.
    Amadio, G.
    di Legge, A.
    Pietragalla, A.
    De Vincenzo, R.
    Masciullo, V.
    Di Stefano, M.
    Mangili, G.
    Citterio, G.
    Mantori, M.
    Lambiase, A.
    Bordignon, C.
    BRITISH JOURNAL OF CANCER, 2012, 107 (01) : 37 - 42
  • [7] Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
    D Lorusso
    G Scambia
    G Amadio
    A di Legge
    A Pietragalla
    R De Vincenzo
    V Masciullo
    M Di Stefano
    G Mangili
    G Citterio
    M Mantori
    A Lambiase
    C Bordignon
    British Journal of Cancer, 2012, 107 : 37 - 42
  • [8] Phase II Study of NGR-hTNF Plus Doxorubicin in Relapsed Ovarian Cancer (OC)
    Lorusso, D.
    Scambia, G.
    Amadio, G.
    Trivellizzi, N.
    Pietragalla, A.
    De Vincenzo, R.
    Salutari, V.
    Di Stefano, M.
    Lambiase, A.
    Bordignon, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S536 - S536
  • [9] Phase II study of NGR-hTNF plus doxorubicin in relapsed ovarian cancer (OC).
    Scambia, G.
    Lorusso, D.
    Amadio, G.
    Trivellizzi, N.
    Pietragalla, A.
    De Vincenzo, R.
    Salutari, V.
    Di Stefano, M.
    Mangili, G.
    Montoli, S.
    Citterio, G.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
    Gregorc, V.
    Santoro, A.
    Bennicelli, E.
    Punt, C. J. A.
    Citterio, G.
    Timmer-Bonte, J. N. H.
    Cappio, F. Caligaris
    Lambiase, A.
    Bordignon, C.
    van Herpen, C. M. L.
    BRITISH JOURNAL OF CANCER, 2009, 101 (02) : 219 - 224
12345